Nature’s Sunshine Products, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Income (loss) Per Share (Tables)

Net Income (loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS

Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March 31, 2023 and 2022 (dollar and share amounts in thousands, except for per share information):


	Three Months Ended March 31,
	2023		2022



Net income (loss) attributable to common shareholders	$	860	$	(2,950)

Basic weighted average shares outstanding	19,061		19,573




Basic earnings (loss) per share attributable to common shareholders	$	0.05	$	(0.15)

Diluted shares outstanding:
Basic weighted-average shares outstanding	19,061		19,573
Stock-based awards	372		—
Diluted weighted-average shares outstanding	19,433		19,573




Diluted earnings (loss) per share attributable to common shareholders	$	0.04	$	(0.15)

Dilutive shares excluded from diluted-per-share amounts:
Share-based awards	520		—

Anti-dilutive shares excluded from diluted-per-share amounts:
Share-based awards	102		282		(1)

_________________________________________

(1) As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.